The increasing interest in successful weight management has led to considerable investigation into cutting-edge treatments. Recently , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has demonstrated promising results in medical trials, indicating potential for substantial weight decre